Hemithoracic Arc Radiotherapy Post Pleural Decortication

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCairo University

About this trial

Malignant Pleural Mesothelioma is an aggressive and refractory disease , the most aggressive treatment plan offered to these patients include trimodalitiy approach with chemotherapy as the mainstay of treatment . the rationale of post operative Radiotherapy is to sterilize the post operative volume to reduce local failure meanwhile minimizing toxicities in this trial we are going to assess the safety and efficacy of Radiotherapy in Mesothelioma patients poat Pleural decortication

Eligibility criteria

Qualifiers

Evidence of metastatic disease.

Underwent Pleural decortication.

Able to provide informed consent.

Disqualifiers

Poor pulmonary function tests.

Recurrent or palliative cases.

Inability to attend full course of Radiotherapy or follow up visits.

Trial design

Treatments tested in this trial

  • hemithoracic Volumetric Arc Radiotherapy post Pleural decortication

Treatment groups

45 Participants
are divided into 1 treatment group

Sponsors and collaborators